Abacavir, dolutegravir, and lamivudine and Dexrazoxane Hydrochloride
Determining the interaction of Abacavir, dolutegravir, and lamivudine and Dexrazoxane Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abacavir / dolutegravir / lamivudine
Brand name: Triumeq
Synonyms: Abacavir, Dolutegravir, and Lamivudine
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abacavir, dolutegravir, and lamivudine-Dexrazoxane Intravenous
- Abacavir, dolutegravir, and lamivudine-Dextenza Insert
- Abacavir, dolutegravir, and lamivudine-Dextenza intraocular
- Abacavir, dolutegravir, and lamivudine-Dextran 40
- Abacavir, dolutegravir, and lamivudine-Dextran 70 6% in 5% Dextrose high molecular weight
- Abacavir, dolutegravir, and lamivudine-Dextran 75
- Dexrazoxane Hydrochloride-Abacavir, Lamivudine and Zidovudine Tablets
- Dexrazoxane Hydrochloride-Abacavir, lamivudine, and zidovudine
- Dexrazoxane Hydrochloride-Abaloparatide
- Dexrazoxane Hydrochloride-Abaloparatide Subcutaneous
- Dexrazoxane Hydrochloride-Abatacept
- Dexrazoxane Hydrochloride-Abatacept Auto-Injectors